LE WE PMID CA
Bone (Metastasis)1464Knochen (Metastase)

Bisphosphonates

Bone (Metastasis)

Bone (Neoplasia)

Dickkopf1

Galliumnitrate

Interleukin6

Kidney (Neoplasia RCC)

Liver (Neoplasia HCC)

LRP5 LDL Receptor Related Protein5 Arrow

Mammary gland (Neoplasia)

Neoplasia (Invasion and metastasis)

Osteoblasts

Osteoporosis

Pancreas (Neoplasia)

Radiation therapy

Src

Thalidomide

Wnt beta Catenin TCF

2008  
1
2008  
2
Zoledronic acid in the management of metastatic bone disease.
[18728715] Ther Clin Risk Manag 4(1): 261-8 (2008)
2007  
3
2005  
4
Controversies in the surgical management of skeletal metastases.
[15855359] J Bone Joint Surg Br 87(5): 608-17 (2005)
2004  
5
Comparative analysis of risk factors for pathological fracture with femoral metastases.
[15174555] J Bone Joint Surg Br 86(4): 566-73 (2004)
2001  
6
The treatment of metastases in the appendicular skeleton.
[11380113] J Bone Joint Surg Br 83(4): 471-81 (2001)
2004  
7
Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline.
[15461823] BMC Cancer 4(-): 71 (2004)
2006  
8
Outcome of surgical management of bony metastases to the humerus and shoulder girdle: a retrospective analysis of 93 patients.
[16509975] Int Semin Surg Oncol 3(-): 5 (2006)
2000  
9
Treatment of metastatic bone disease in breast cancer: bisphosphonates.
[11899389] Clin Breast Cancer 1(1): 43-51 (2000)
2009  
10
Prevention and management of bone metastases in lung cancer: a review.
[19179905] J Thorac Oncol 4(2): 251-9 (2009)
2007  
11
Molecular biology of bone metastasis.
[17938257] Mol Cancer Ther 6(10): 2609-17 (2007)
2006  
12
Bisphosphonates and metastatic bone disease.
[16608996] Ann Oncol 17 Suppl 2(-): ii91-95 (2006)
2003  
13
Mechanisms of osteolytic bone metastases in breast carcinoma.
[12548583] Cancer 97(3 Suppl): 834-9 (2003)
2003  
14
Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications.
[12548574] Cancer 97(3 Suppl): 772-8 (2003)
2003  
15
Animal models of bone metastasis.
[12548572] Cancer 97(3 Suppl): 748-57 (2003)
2003  
16
Stromal factors involved in prostate carcinoma metastasis to bone.
[12548571] Cancer 97(3 Suppl): 739-47 (2003)
2003  
17
Role of stromal-derived cytokines and growth factors in bone metastasis.
[12548570] Cancer 97(3 Suppl): 733-8 (2003)
2003  
18
The development and function of the skeleton and bone metastases.
[12548569] Cancer 97(3 Suppl): 726-32 (2003)
2000  
19
The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma.
[10898342] Cancer 88(12 Suppl): 2989-94 (2000)
2000  
20
Markers of bone turnover in bone metastases.
[10898339] Cancer 88(12 Suppl): 2952-60 (2000)
2000  
21
Complications of bone metastases: surgical management.
[10898338] Cancer 88(12 Suppl): 2940-51 (2000)
2000  
22
Biochemical markers and skeletal metastases.
[10898335] Cancer 88(12 Suppl): 2919-26 (2000)
2000  
23
Pathophysiologic interactions in skeletal metastasis.
[10898334] Cancer 88(12 Suppl): 2912-8 (2000)
2000  
24
Molecular basis of the spectrum of skeletal complications of neoplasia.
[10898332] Cancer 88(12 Suppl): 2903-8 (2000)
2000  
25
Molecular mechanisms of osteolytic bone metastases.
[10898330] Cancer 88(12 Suppl): 2892-8 (2000)
2000  
26
Oral bisphosphonates: A review of clinical use in patients with bone metastases.
[10618600] Cancer 88(1): 6-14 (2000)
1997  
27
Gallium nitrate for the treatment of bone metastases.
[9362436] Cancer 80(8 Suppl): 1680-5 (1997)
1997  
28
Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals.
[9362430] Cancer 80(8 Suppl): 1628-45 (1997)
1997  
29
Orthopedic surgical management of skeletal complications of malignancy.
[9362429] Cancer 80(8 Suppl): 1614-27 (1997)
1997  
30
Radiologic diagnosis of bone metastases.
[9362427] Cancer 80(8 Suppl): 1595-607 (1997)
1997  
31
Skeletal complications of malignancy.
[9362426] Cancer 80(8 Suppl): 1588-94 (1997)
1997  
32
Mechanisms of the development of osteoblastic metastases.
[9362425] Cancer 80(8 Suppl): 1581-7 (1997)
1997  
33
Parathyroid hormone-related protein and bone metastases.
[9362424] Cancer 80(8 Suppl): 1572-80 (1997)
1997  
34
Mechanisms of bone metastasis.
[9362421] Cancer 80(8 Suppl): 1546-56 (1997)
2008  
35
Understanding the biology of bone metastases: key to the effective treatment of prostate cancer.
[18347159] Clin Cancer Res 14(6): 1599-602 (2008)
2006  
36
Targeting bone metastasis in prostate cancer with endothelin receptor antagonists.
[17062717] Clin Cancer Res 12(20 Pt 2): 6296s-6300s (2006)
2006  
37
SRC inhibitors in metastatic bone disease.
[17062716] Clin Cancer Res 12(20 Pt 2): 6291s-6295s (2006)
2006  
38
Clinical features of metastatic bone disease and risk of skeletal morbidity.
[17062708] Clin Cancer Res 12(20 Pt 2): 6243s-6249s (2006)
2006  
39
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
[17062703] Clin Cancer Res 12(20 Pt 2): 6213s-6216s (2006)
2003  
40
Clinical approaches to osseous metastases in prostate cancer.
[12697941] Oncologist 8(2): 161-73 (2003)
2000  
41
Management of bone metastases.
[11110597] Oncologist 5(6): 463-70 (2000)
2006  
42
Metastatic tumors in the jaws: a retrospective study of 114 cases.
[17138711] J Am Dent Assoc 137(12): 1667-72 (2006)
2007  
43
Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patients.
[17406908] Eur Spine J 16(8): 1179-92 (2007)
2010  
44
Total en bloc spondylectomy for lung cancer metastasis to the spine.
[20887137] J Neurosurg Spine 13(4): 414-7 (2010)
2009  
45
Thoracic vertebrectomy and spinal reconstruction via anterior, posterior, or combined approaches: clinical outcomes in 91 consecutive patients with metastatic spinal tumors.
[19769508] J Neurosurg Spine 11(3): 272-84 (2009)
2006  
46
Cancer interaction with the bone microenvironment: a workshop of the National Institutes of Health Tumor Microenvironment Study Section.
[16651608] Am J Pathol 168(5): 1405-12 (2006)
2009  
47
Mechanisms of bone metastases of breast cancer.
[19443538] Endocr Relat Cancer 16(3): 703-13 (2009)
2008  
48
Bone metastases from differentiated thyroid carcinoma.
[18310274] Endocr Relat Cancer 15(1): 37-49 (2008)
2005  
49
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
[16172192] Endocr Relat Cancer 12(3): 549-83 (2005)
2004  
50
The role of bisphosphonates in breast and prostate cancers.
[15163299] Endocr Relat Cancer 11(2): 207-24 (2004)
1999  
51
Factors regulating the growth of metastatic cancer in bone.
[10516850] Endocr Relat Cancer 6(3): 333-47 (1999)
2003  
52
Clinical review 165: Markers of bone remodeling in metastatic bone disease.
[14602728] J Clin Endocrinol Metab 88(11): 5059-75 (2003)
2005  
53
Prostate cancer cell survival pathways activated by bone metastasis microenvironment.
[15951629] J Musculoskelet Neuronal Interact 5(2): 135-44 (2005)
2004  
54
Tumor-bone cellular interactions in skeletal metastases.
[15615499] J Musculoskelet Neuronal Interact 4(3): 308-18 (2004)
2008  
55
Radiofrequency ablation of osseous metastases for the palliation of pain.
[18030464] Skeletal Radiol 37(3): 189-94 (2008)
2005  
56
Diagnosis and treatment of vertebral column metastases.
[16178498] Mayo Clin Proc 80(9): 1177-86 (2005)
1986  
57
Radiologic contributions to cancer management. Bone metastases.
[2425614] AJR Am J Roentgenol 147(2): 305-12 (1986)
1981  
58
Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review.
[6787858] AJR Am J Roentgenol 137(1): 103-8 (1981)
2002  
59
Bone metabolic markers as gauges of metastasis to bone: a review.
[12126040] Ann Nucl Med 16(3): 161-8 (2002)
2005  
60
Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
[16085595] J Nucl Med 46(8): 1356-67 (2005)
2007  
61
Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).
[17549396] Int J Mol Med 20(1): 103-11 (2007)
2005  
62
The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasis.
[16172737] Braz J Med Biol Res 38(10): 1449-54 (2005)
2006  
63
Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis.
[17057075] Radiology 241(2): 572-80 (2006)
2005  
64
CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.
[16244271] Radiology 237(2): 627-34 (2005)
2006  
65
Pathophysiology of bone metastases.
[17012831] Cancer Biol Ther 5(9): 1078-81 (2006)
2008  
66
Biology of breast cancer bone metastasis.
[18059174] Cancer Biol Ther 7(1): 3-9 (2008)
2011  
67
Metastatic lesions of the proximal femur.
[21332443] Bull NYU Hosp Jt Dis 69(1): 81-6 (2011)
2009  
68
The role of Dickkopf-1 in bone development, homeostasis, and disease.
[18687985] Blood 113(3): 517-25 (2009)
2011  
69
External beam radiotherapy in the management of spinal metastases: review of current strategies and perspectives for highly conformal irradiation modalities.
[21712016] Discov Med 11(61): 505-11 (2011)
2010  
70
Pathogenesis of osteoblastic bone metastases from prostate cancer.
[20108337] Cancer 116(6): 1406-18 (2010)
2011  
71
Therapeutic targets for bone metastases in breast cancer.
[21586099] Breast Cancer Res 13(2): 207 (2011)
2010  
72
Breast cancer metastasis to the bone: mechanisms of bone loss.
[21176175] Breast Cancer Res 12(6): 215 (2010)
2008  
73
Fatal attraction: why breast cancer cells home to bone.
[18226190] Breast Cancer Res 10(1): 101 (2008)
2008  
74
A primer of bone metastases management in breast cancer patients.
[18231649] Curr Oncol 15(Suppl 1): S50-7 (2008)
2011  
75
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.
[21625400] Cancer Manag Res 3(-): 177-89 (2011)
2010  
76
Renal cell carcinoma bone metastases: clinical advances.
[21789128] Ther Adv Med Oncol 2(2): 75-83 (2010)
2007  
77
Surgical management of metastatic disease of the proximal femur.
[18162673] J Orthop Surg (Hong Kong) 15(3): 295-8 (2007)
2009  
78
The management of spinal metastases from renal cell carcinoma.
[19686617] Ann R Coll Surg Engl 91(8): 649-52 (2009)
2004  
79
Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease.
[16985930] Rev Urol 6 Suppl 10(-): S3-S12 (2004)
2010  
80
Collagenous and non-collagenous biochemical markers of bone metastases from prostate cancer.
[20981164] Hippokratia 14(3): 164-9 (2010)
2010  
81
Interleukin-6 in bone metastasis and cancer progression.
[20335016] Eur J Cancer 46(7): 1223-31 (2010)
2011  
82
Bone metastasis: mechanisms and therapeutic opportunities.
[21200394] Nat Rev Endocrinol 7(4): 208-18 (2011)
2007  
83
Bone metastasis from primary hepatocellular carcinoma: characteristics of soft tissue formation.
[19746218] Cancer Res Treat 39(3): 104-8 (2007)
2005  
84
Mechanisms of cancer metastasis to the bone.
[15686629] Cell Res 15(1): 57-62 (2005)
2011  
85
Breast cancer at bone metastatic sites: recent discoveries and treatment targets.
[21484191] J Cell Commun Signal 5(2): 85-99 (2011)
2009  
86
Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature.
[19325940] Yale J Biol Med 82(1): 1-6 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia